Company Overview and News

1
China stocks fall as Trump threatens tariffs on additional $267 bn of imports

2018-09-10 thehindubusinessline
At the midday break, the Shanghai Composite index was down 17 points or 0.63 per cent to 2,685.30.
GGDVF WRFRF DB 0390 CRWOF AXB TGBA 500800 TTAZF 0270 532215 1044 TTAEY CRWOY AXBKY TGBL AXBA GGDVY AXISBANK AAPL 0914 TATAGLOBAL

1
Hong Kong shares end lower as investors brace for trade war escalation

2018-09-10 theedgemarkets
(Sept 10): Hong Kong shares hit near-14-month lows on Monday to end lower for the day, tracking a regional slump as investors braced for the ratcheting up of a trade war between the United States and China.
CRWOY 0489 GGDVF GGDVY WRFRF 0390 CRWOF AAPL 0914 0270

6
HK stocks hit six-month closing low as trade war fears persist

2018-06-21 theedgemarkets
SHANGHAI (June 21): Hong Kong stocks ended at a six-month low on Thursday, as China-US trade conflict fears curbed risk appetite.
CRWOY 0390 CGHLY CRWOF 0914 CGHOF CEO 0384

 
China seen flexing loan muscle as it pushes farther into Pacific, tentacles reach Papua New Guinea

2018-06-18 japantimes.co.jp
CANBERRA – In the gritty, steamy streets of Papua New Guinea’s capital Port Moresby, signs of China’s push into the Pacific island nation are inescapable.
CRWOY 0390 CRWOF

 
China’s bid for global influence reaches the pacific islands

2018-06-18 malaymail
CANBERRA, June 18 — In the gritty, steamy streets of Papua New Guinea’s capital Port Moresby, signs of China’s push into the Pacific island nation are inescapable.
CRWOY 0390 CRWOF

 
High-speed rail builder China Railway swaps out debt for US$1.8 billion in fresh cash

2018-06-14 scmp
The company, at the forefront of the country’s ‘railway diplomacy’, is expected to play a big role in the country’s belt and road global trade push
CRWOY 1359 0390 CRWOF

 
HK stocks fall ahead of next week's Trump-Kim summit, Fed meeting

2018-06-08 theedgemarkets
SHANGHAI (June 8): Hong Kong stocks fell the most in two weeks on Friday, as investors braced for a series of market-moving events next week including the US-North Korea summit and the Federal Reserve's policy meeting.
SWRAY CRWOY SWRBY 0390 CGHLY CRWOF SWRBF SWRAF CGHOF 0384 1099

 
MSCI drops ZTE, four other companies from MSCI China A Inclusion Index

2018-05-30 reuters
SINGAPORE (Reuters) - Telecom equipment and smartphone maker ZTE Corp (000063.SZ) (0763.HK) and four other companies have been dropped from several MSCI indexes including the MSCI China A Inclusion Index as trading in the China-listed A shares of all five companies has been suspended.
CRWOY 0390 CRWOF

1
China’s Communists Rewrite the Rules for Foreign Businesses - The New York Times

2018-04-14 nytimes
The party is strengthening its influence — often gaining direct decision-making power — over the international firms doing business in China.
CRWOY 0489 0390 CRWOF 2601 NYTAB

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...